What You Should Know:
- Fortrea, a global contract research organization (CRO), and Medidata, a Dassault Systèmes company specializing in clinical trial solutions, announced an AI-powered partnership to increase diversity in clinical trials.
- The collaboration aims to leverage Medidata's AI technology, specifically Medidata AI Intelligent Trials, to increase access to diverse patients in Fortrea-conducted clinical trials.
Increase Diversity in Clinical Trails
This partnership builds
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Medable & Pluto Health Partner to Increase Patient Access to Clinical Trials
What You Should Know:
- Medable Inc., a technology provider for modern clinical trials forms an enterprise partnership with Pluto Health, a smart care coordination services company.
- The partnership brings together two best-in-class technology solutions in healthcare to streamline clinical trial execution, improve data quality in trials, and enhance the patient experience from study start and long after the trial is over.
Optimize Patient Experience and Improve Access
Read More
Atropos Health Partners, Janssen Partner to Accelerate Clinical Trials with RWD
What You Should Know:
Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced an agreement with Janssen Research & Development, LLC (Janssen), a Johnson & Johnson company, to help accelerate clinical development with real-world data analysis.Building upon an existing collaboration, under the new agreement, Atropos and Janssen data scientists will utilize Atropos’s software platform to interrogate
Read More
Belong.Life Launches AI Clinical Trial Matching Assistant for Cancer
What You Should Know:
- Belong.Life today announced the launch of Tara, a new conversational AI SaaS solution to assist health providers and CROs with cancer clinical trial matching and recruitment.
- Available as a SaaS solution for providers, hospitals, health systems, CROs and other organizations, the technology can be embedded into websites, mobile apps or text messaging platforms to enable easy communication with opt-in patients.
AI SaaS Solution for Cancer Clinical Trial
Read More
myTomorrows, Congenica Partner to Advance Precision Oncology by Accelerating Clinical Trial Recruitment
What You Should Know:
- Congenica, a digital health company specializing in the provision of software and solutions for genomic data analysis and interpretation, and myTomorrows, a global platform facilitating access to pre-approval treatments and clinical trials, have partnered to expedite access to precision oncology for cancer patients worldwide.
- The strategic partnership between Congenica and myTomorrows will open new opportunities for physicians to search for access to
Read More
QuantHealth Secures $15M for AI-Powered Clinical Trial Design
What You Should Know:
- QuantHealth, an Israeli-based AI-powered clinical trial design startup raises $15M in a Series A funding round co-led by Bertelsmann Investments and Pitango HealthTech, with participation from existing investors Shoni Top Ventures and Nina Capital.
- The round also includes participation from previous investors including Boston Millennia Partners, Atooro Fund, and Renegade Ventures. The latest round of funding brings QuantHealth to $20M in funding to
Read More
Q/A: AiCure SVP Talks How Digital Health Can Improve Access to Clinical Trials
The imperative to enhance access to quality care and research is a central concern gripping both the healthcare and pharmaceutical sectors. At the heart of this challenge lies the crucial necessity for clean and streamlined patient data, which currently suffers from inadequacies in comprehensiveness and accuracy. Addressing this pivotal issue carries immense benefits, particularly in the sphere of targeted trial recruitment efforts. By harnessing better patient data records, the possibilities
Read More
How to Achieve Health Equity in Decentralized Clinical Trials
Trial sponsors have made efforts to address underrepresentation and promote Diversity, Equity and Inclusion (DEI) in clinical trials since the Federal and Drug Administration’s (FDA) 2016 guidance, but a new report released by the Government Accountability Office (GAO) still shows a continuous presence of major gaps in patient diversity. It begs the question: how do we ultimately achieve full representation and ensure accountability to uphold the promises we have made for
Read More
Walgreens and Freenome Partner to Increase Diversity in Research
What You Should Know:
Walgreens and Freenome form a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer. Walgreens will combine its national footprint, patient insights, compliant recruitment technology and local infrastructure to engage diverse patient populations in Freenome’s multi-cancer research program. Walgreens will initially recruit patients across diverse populations for Freenome’s Sanderson Study, which aims to
Read More
Navigating the Challenges of Biosample Consent in Clinical Trials
In the age of biotechnology, biosample collection has become an essential part of medical research. Through this process, samples are taken from patients through a variety of sources, including blood, tissue, saliva, hair, and other bodily fluids. The samples are then analyzed for their genetic, biochemical, or physiological properties, and the findings are used to further the understanding of human health, disease and the environment.
Many times, during clinical trials, sponsors will want to
Read More
